Page last updated: 2024-11-05

wb 4101 and Complex Regional Pain Syndrome

wb 4101 has been researched along with Complex Regional Pain Syndrome in 1 studies

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dubuis, E1
Thompson, V1
Leite, MI1
Blaes, F1
Maihöfner, C1
Greensmith, D1
Vincent, A1
Shenker, N1
Kuttikat, A1
Leuwer, M1
Goebel, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
INFLUENCE of THORACIC MANIPULATION on TYPE 1 COMPLEX REGIONAL PAIN SYNDROME Post-UPPER LIMB TRAUMA[NCT04769128]30 participants (Actual)Interventional2018-07-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for wb 4101 and Complex Regional Pain Syndrome

ArticleYear
Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors.
    Pain, 2014, Volume: 155, Issue:11

    Topics: Adult; Animals; Atropine; Autoantibodies; Calcium; Cells, Cultured; Complex Regional Pain Syndromes;

2014